Breast Cancer: Chemotherapy
2026-05-31 · Department of Health and Social Care · HL516 · Official question
Baroness Ritchie of Downpatrick
Question
To ask His Majesty's Government what assessment they have made of the potential for genomic testing to identify which breast cancer patients require chemotherapy and which do not, in light of the recent trial by University College London entitled Optimal
Answer
The Government and NHS England recognise the importance of genomic testing to support more personalised treatment for cancer patients, including those with breast cancer. While decisions on specific treatment pathways, including the use of chemotherapy fo...